Stratus Versus Cirrus OCT in AMD

Reliability of Threshold Algorithm in Age-Related Macular Degeneration: Stratus Versus Cirrus OCT

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00568191

Enrollment

100

Registered

2007-12-05

Start date

2007-10-31

Completion date

2007-12-31

Last updated

2007-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Macular Degeneration, Choroidal Neovascularization

Keywords

Age-related macular degeneration, choroidal neovascularization, Stratus OCT, Cirrus OCT

Brief summary

The Cirrus OCT provides due to the spectral domain technology a 2-fold resolution than Stratus OCT generated in a comparable amount of time. Due to this higher resolution the retinal surface and the retinal pigment epithelium can be identified more clearly, a significantly reduced number of algorithm failures is expected

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

55 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age\>55 years * Age-related macular degeneration

Exclusion criteria

* Not consented patients

Design outcomes

Primary

Measure	Time frame
Number of algorithm failures assessed by Stratus OCT versus Cirrus OCT in the horizontal central line	only 1 examination

Secondary

Measure	Time frame
Number of algorrithm failures in Stratus versus Cirrus OCT assessed in the whole scan	1 examination

Countries

Austria

Contacts

Primary ContactIlse Krebs, MD

Ilse.Krebs@wienkav.at+43171165

Outcome results